Extension Letter to Consulting Agreement between Cerulean Pharma Inc. and Danforth Advisors, LLC (May 27, 2016)
Cerulean Pharma Inc. and Danforth Advisors, LLC have agreed to extend their existing consulting agreement for an additional year, through May 26, 2017. This letter confirms the extension and requires Danforth Advisors to countersign to indicate acceptance. The agreement ensures the continued provision of consulting services by Danforth Advisors to Cerulean Pharma Inc. under the same terms as the original agreement.
Exhibit 10.1
May 27, 2016
Gregg Beloff
Danforth Advisors, LLC
91 Middle Road
Southborough, MA
01772
Dear Gregg:
This letter is in reference to the Consulting Agreement between Cerulean Pharma Inc. ("Cerulean") and Danforth Advisors, LLC dated May 27, 2015 (the "Agreement"). Capitalized terms used herein and not otherwise defined shall have the meaning given such terms in the Agreement.
As Cerulean desires your continued services, you and Cerulean hereby agree to an extension of the term of the Agreement through May 26, 2017.
If this extension meets with your approval, please countersign a copy of this letter and return one copy to the undersigned.
Very truly yours,
CERULEAN PHARMA INC.
| By: | /s/ Christopher D. T. Guiffre |
|
| Christopher D. T. Guiffre |
|
| President & CEO |
Agreed to:
DANFORTH ADVISORS, LLC
| By: | /s/ Gregg Beloff |
|
| Gregg Beloff |
|
| Managing Director |
Cerulean Pharma Inc. | 35 Gatehouse Drive I Waltham, MA 02451 1 P: 781 ###-###-#### 1 F: 844 ###-###-####
